what not to take with bpc 157 GLP-1 medications and peptide therapies are everywhere right now—but they're all the same. recent headlines about compounded peptides, many of you have reached out asking: What's the difference? Are they BPC-157 Peptide | The Hidden

Vukojevic et al., 2020) or reduced L-NAME-induced retinal ischemia in rats (Zlatar et al., 2021)

The mechanistic plausibility is strong (NNMT inhibition increases NAD+ without the gastrointestinal side effects of high-dose nicotinamide), and the short-term tolerability profile is excellent, but we mean this sincerely: if you're using this compound for durations beyond what the published trials covered, you are operating in uncharted territory

A clean, sterile, and effective administration

This pathway can absorb approximately 1.52 micrograms per meal , making it efficient for dietary B12 but limited for high-dose supplementation

This is perfect for bypassing the skin and entering the subcutaneous fat layer without hitting muscle

NNMT dysregulation is implicated across obesity, insulin resistance, liver pathology, and other disorders